The present invention relates to an osteochondral composite scaffold for articular cartilage repair, particularly a composite scaffold in a cylindrical plug form for articular cartilage repair.
Osteoarthritis not only will cause wearing of articular cartilage, but also, when in its severe state, will cause the blood vessels of the bone under the articular cartilage penetrating through the calcified layer and into the cartilage zone, and cause an excessive growth of the bone, thereby forming spur and completely sabotaging the functions of the articular cartilage. Generally, when a tissue engineering scaffold is implanted into the joint of a patient suffering from osteoarthritis, the damages on the articular cartilage will reoccur in a short term due to excessive growth of the bone even the damages are fully repaired initially, because the penetration of the blood vessels from the bone under the articular cartilage can not be stopped. Therefore, the recurrence of osteoarthritis can be avoided only if the damaged cartilage and the calcified region, together with the bone underneath, are replaced with a tissue engineering scaffold with a separation layer.
One objective of the present invention is to provide a tissue engineering scaffold to be applied on articular cartilage repair.
The present invention provides an osteochondral composite scaffold simulating an articular joint for articular cartilage repair, wherein the composite scaffold can promote in vitro culture of articular chondrocytes.
An osteochondral composite scaffold for the repair of articular cartilage constructed according to the present invention includes a dense layer for separating the cartilage zone from the bone zone (i.e. a separation layer) in order to achieve the effect of preventing blood vessels from penetrating into the cartilage zone from the bone zone.
Preferred embodiments of the present invention include (but not limited to) the following:
1. An osteochondral composite scaffold for articular cartilage repair, which comprises:
a lower porous ceramic layer intimating the bone zone of an articular joint;
an upper porous ceramic layer intimating the bottom cartilage zone of the joint; and
a dense ceramic separation layer connecting the lower porous ceramic layer to the upper porous ceramic layer; and
optionally a porous bio-polymer matrix layer affixed to the upper porous ceramic layer, intimating the middle cartilage zone of the joint.
2. The composite scaffold as recited in Item 1, wherein the separation layer is a hardened or sintered calcium phosphate cement, calcium sulfate cement, or bioglass, with a pore size less than 5 μm.
3. The composite scaffold as recited in Item 2, wherein the separation layer is a hardened or sintered calcium phosphate cement.
4. The composite scaffold as recited in Item 3, wherein the calcium phosphate cement comprises tricalcium phosphate powder.
5. The composite scaffold as recited in Item 2, wherein the separation layer has a thickness less than 1 mm.
6. The composite scaffold as recited in Item 1, which comprises the porous bio-polymer matrix layer.
7. The composite scaffold as recited in Item 6, wherein the porous bio-polymer matrix layer is gelatin or collagen.
8. The composite scaffold as recited in Item 7, wherein the gelatin or collagen is a cross-linked gelatin or collagen by a cross-linking agent.
9. The composite scaffold as recited in Item 6, wherein the porous bio-polymer matrix layer has a porosity of 90-95 vol % and a pore size of 200-500 μm.
10. The composite scaffold as recited in Item 6, wherein the porous bio-polymer matrix layer has a thickness of 1-3 mm.
11. The composite scaffold as recited in Item 1, wherein the lower porous ceramic layer is a hardened or sintered calcium phosphate cement, calcium sulfate cement, or bioglass, with a porosity of 20-30 vol % and a pore size of 100-200 μm.
12. The composite scaffold as recited in Item 11, wherein the lower porous ceramic layer is a sintered calcium phosphate cement.
13. The composite scaffold as recited in Item 12, wherein the calcium phosphate cement comprises calcium polyphosphate powder.
14. The composite scaffold as recited in Item 11, wherein the lower porous ceramic layer has a thickness of 2-5 mm.
15. The composite scaffold as recited in Item 1, wherein the upper porous ceramic layer is a hardened or sintered calcium phosphate cement, calcium sulfate cement, or bioglass, with a porosity of 10-50 vol % and a pore size of 50-300 μm.
16. The composite scaffold as recited in Item 15, wherein the upper porous ceramic layer is a sintered calcium phosphate cement.
17. The composite scaffold as recited in Item 16, wherein the calcium phosphate cement comprises calcium polyphosphate powder.
18. The composite scaffold as recited in Item 15, wherein the upper porous ceramic layer has a thickness of 0.2-2 mm.
19. The composite scaffold as recited in Item 1, which is a cylinder with a diameter of 5-20 mm.
20. The composite scaffold as recited in Item 6, which further comprises chondrocytes adhered to and tissues grown in the porous bio-polymer matrix layer.
21. A method for preparing an osteochondral composite scaffold for articular cartilage repair, which comprises:
a) compressing a first porous ceramic precursor powder to form a lower porous ceramic layer green body;
b) disposing a dense ceramic separation layer on a surface of the lower porous ceramic layer green body; or coating a layer of a paste formed of a dense ceramic precursor powder and an aqueous solution on the surface of the green body, and hardening the paste on the surface to form a dense ceramic separation layer;
c) disposing a hollow columnar mold on the separation layer, and pouring a second porous ceramic precursor powder into the mold to stack the second porous ceramic precursor powder on the separation layer; or compressing a second porous ceramic precursor powder to form an upper porous ceramic layer green body, and disposing the green body on the separation layer; and
d) sintering the resulting stacked structure from step c) to form a sandwiched structure formed of an upper porous ceramic layer, a separation layer, and a lower porous ceramic layer.
22. The method as recited in Item 21, which further comprises:
e) preparing a bio-polymer solution;
f) disposing a hollow columnar mold on the upper porous ceramic layer of the sandwiched structure, pouring the bio-polymer solution into the mold to form a reservoir of the bio-polymer solution, cooling the reservoir to form a gel-like material and then removing the mold;
g) contacting the gel-like material with an aqueous solution containing a cross-linking agent to form a cross-linked bio-polymer block; and
h) washing the cross-linked bio-polymer block, and freeze-drying the washed block to form a porous bio-polymer matrix layer affixed to the upper porous ceramic layer.
23. The method as recited in Item 21, which further comprises:
e′) preparing an aqueous solution containing a bio-polymer and a cross-linking agent;
f′) disposing a hollow columnar mold on the upper porous ceramic layer of the sandwiched structure, pouring the aqueous solution into the mold to form a reservoir, cooling the reservoir to form a gel-like material and then removing the mold;
g′) aging the gel-like material to form a cross-linked bio-polymer block; and
h) washing the cross-linked bio-polymer block, and freeze-drying the washed block to form a porous bio-polymer matrix layer affixed to the upper porous ceramic layer.
24. The method as recited in Item 22, which further comprises:
i) wetting the porous bio-polymer matrix layer, and then freeze-drying the matrix layer to form a porous bio-polymer matrix layer with a different structure.
25. The method as recited in Item 23, which further comprises: i) wetting the porous bio-polymer matrix layer, and then freeze-drying the matrix layer to form a porous bio-polymer matrix layer with a different
As shown in
a lower porous ceramic layer 10 intimating the bone zone of the articular joint;
an upper porous ceramic layer 20 intimating the bottom cartilage zone of the articular joint;
a dense ceramic separation layer 30 connecting the lower porous ceramic layer to the upper porous ceramic layer; and
a porous gelatin layer 40, intimating the middle cartilage zone of the articular joint, affixed to the upper porous ceramic layer.
In the present invention, for the purpose of accelerating the rate of in vitro culture of articular chondrocytes, a porous gelatin layer 40 for accelerating the growth of cartilage tissues is affixed to the porous ceramic layer 20. In addition to gelatin, which is a biological polymer, any polymer material capable of accelerating the rate of in vitro chondrocyte culture can also be used.
The function of each layer in the composite scaffold of the present invention is described as follows:
(1) The lower porous ceramic layer 10 intimating the bone zone of the articular joint: intimating subchondral bone, cancellous bone, and cortical bone. The material for the bone zone is selected from calcium phosphate, which is a biomedical ceramic material, e.g. β-calcium polyphosphate (β-CPP), with a thickness of 3 mm, a porosity of 20˜30 vol %, and a pore size of about 100˜200 μm.
(2) The upper porous ceramic layer 20 intimating the bottom cartilage zone of the articular joint: intimating the calcified zone of the articular cartilage. The material intimating the calcified zone of the articular cartilage (cartilage bottom layer) is selected from calcium phosphate, β-CPP, with a thickness of 0.2˜2 mm, a porosity of 10˜50 vol %, a pore size of 50˜300 μm, which may vary depending on whether the porous gelatin layer 40 is provided.
(3) The porous gelatin layer 40 intimating the middle cartilage zone of the articular joint: the matrix of the layer 40 has a thickness of 2 mm, a porosity of 90˜95 vol %, and a pore size of 200˜500 μm. The porous gelatin layer 40 can be made from pigskin gelatin. The gelatin is a denatured product of collagen and contains a RGD sequence capable of assisting the adhesion and growth of chondrocytes, as well as maintaining the cell activities. However, an un-processed gelatin is easy to degrade, and a gelatin will absorb water, becoming soft and lack of sufficient anti-compression mechanical strength. Thus, preferably, gelatin is cross-linked by a cross-linking agent, e.g. glutaraldehyde (GA) or genipin (GP), to enhance the thermal stability and anti-compression strength of the structure of the porous gelatin layer 40.
(4) Separation layer 30: a thin layer separating the bone zone from the cartilage zone. The material for the separation layer is selected from calcium phosphate, e.g. β-tricalcium phosphate (β-TCP). The separation layer is the thinner the better, wherein the separation layer needs to have a porosity <5 vol % and a pore size <5 μm.
Experiments
1. Preparation of Composite Scaffold (wherein the processes for preparing the separation layer and the porous gelatin layer will be described following this section)
A process for preparing the porous gelatin layer comprised converting a gelatin at a low temperature into a jelly-like gel; immersing the jelly-like gel in a solution of a cross-linking agent to undergo a cross-linking reaction; upon completion of the reaction, performing washing, freezing, and freeze-drying steps.
Experimental Steps:
This process can be used to produce a single porous gelatin matrix, used as an individual scaffold, which only requires pouring the solution of step (1) into a cylindrical container (mold) as in step (2). The rest of the steps remained the same.
In the present invention, the process of affixing the porous gelatin layer to the porous ceramic layer can also adopt the following simple step (2′) before the steps (4)˜(7), i.e. replacing the steps (2)˜(3) with:
1. Evaluation of the Separation Layer
The separation layer is a thin layer separating the cartilage zone from the bone zone with a function of stopping the blood vessels in the bone zone to penetrate into the cartilage zone. The material of the separation layer was β-TCP. The separation layer was the thinner the better (where the thickness of the separation layer can be very small if a coating process is used). The separation layer needs to have a porosity of <5 vol %, and a pore size <5 μm.
According to the experimental results, the sintered β-TCP separation layer had a diameter of 8.36 mm and a thickness of 0.61 mm. The porosity of the TCP separation layer was reduced from 46 vol % before sintering to 3 vol % after sintering. A Scanning Electron Microscopy (SEM) photograph shows that the TCP separation layer has almost no pores. Thus, the β-TCP ceramic film is a suitable separation layer material.
2. Evaluation of Composite Scaffold (Evaluation of Porous Gelain Layer will be Described Following this Section) —Effect on Chondrocyte Culture
The content of the glycosaminoglycan (GAG) in the extracellular matrix of the cartilage tissues grown in the tissue engineering scaffold should be 3˜5 times of the content of hydroxyproline (HP) so as to conform to the composition of extracellular matrix of natural cartilage tissues. The results of this experiment complied with this requirement quite well.
After about one month of in vitro culture, the slice of the composite scaffold of this experiment stained by toluidine blue are similar to that of the slice of a natural cartilage.
3. Evaluation of the Porous Gelatin Layer
After the porous gelatin layer was affixed to the upper porous ceramic layer, an experiment was carried out by shaking the composite scaffold in an aqueous solution simulating the in vitro culture of cartilage tissue. The experimental results show that the adhesion between the porous gelatin layer and the upper porous ceramic layer is strong and the porous gelatin layer does not delaminate from the upper porous ceramic layer. This adhesion can be enhanced by adjusting parameters such as the porosity and thickness of the upper porous ceramic layer. The following text will describe the properties of a single porous gelatin matrix, used as an individual scaffold, and their influences on chondrocyte culture in order to identify the factors of the process for preparing the porous gelatin layer of the present invention.
An experiment was carried out to observe the performance of a porous gelatin matrix cross-linked at 25° C.: The results indicate that the porous gelatin matrix show no dissolution or disintegration. The SEM observations on the GA- and GP- cross-linked porous gelatin matrixes show that the pore sizes of the matrixes substantially are within 300˜500 μm for those being subjected to the freeze-drying treatment once or twice. The walls of the porous gelatin matrix receiving the freeze-drying treatment twice are conspicuously different from the walls of the porous gelatin scaffold receiving the freeze-drying treatment once. As shown in
Other than GP and GA, the present invention can also adopt other cross-linking agents to carry out cross-linking of the gelatin in order to form a porous gelatin layer or gelatin matrix with a sufficient mechanical strength.
After 30 days of culture, the appearance of the porous gelatin matrix (as shown in
4. Conclusion of Evaluation:
In view of above it can be concluded that the composite scaffold of the invention is a biomedical scaffold material suitable for articular cartilage repair.
In another embodiment of the invention, a sandwiched scaffold without the porous gelatin layer was implanted with chondrocytes for cell culture experiment. The experimental results indicate that the sandwiched scaffold free of the porous gelatin layer can also grow a cartilage tissue similar to the natural articular cartilage tissue (with a slower growth rate). Thus, a sandwiched scaffold without a porous gelatin layer can also be used as a biomedical scaffold material suitable for articular cartilage repair.
Number | Date | Country | Kind |
---|---|---|---|
94139017 | Nov 2005 | TW | national |